When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNJ - XBiotech out-licenses anti-inflammatory antibody to Janssen for up to $1.35B
Johnson & Johnson
XBiotech (NASDAQ:XBIT) inks an agreement with Johnson & Johnson (NYSE:JNJ) unit Janssen Biotech for global rights to anti-inflammatory candidate bermekimab.
More news on: XBiotech Inc., Johnson & Johnson, Healthcare stocks news, Stocks on the move,